BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6283820)

  • 1. The effect of substrates and inhibitors of monoamine oxidase on hepatic dimethylnitrosamine metabolism and mutagenicity.
    Lake BG; Rowland IR; Harris RA; Collins MA; Phillips JC; Cottrell RC; Gangolli SD
    Adv Exp Med Biol; 1981; 136 Pt B():1143-7. PubMed ID: 6283820
    [No Abstract]   [Full Text] [Related]  

  • 2. Substrates and inhibitors of hepatic amine oxidase inhibit dimethylnitrosamine-induced mutagenesis in Salmonella typhimurium.
    Rowland IR; Lake BG; Phillips JC; Gangolli SD
    Mutat Res; 1980 Aug; 72(1):63-72. PubMed ID: 7003365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glutathione and uridine 5'-diphosphoglucuronic acid on benzo(a)pyrene mutagenesis in the Salmonella/microsome assay.
    Malaveille C; Brun G; Hautefeuille A; Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():175-80. PubMed ID: 6273102
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin K as a regulator of benzo(a)pyrene metabolism, mutagenesis, and carcinogenesis. Studies with rat microsomes and tumorigenesis in mice.
    Israels LG; Walls GA; Ollmann DJ; Friesen E; Israels ED
    J Clin Invest; 1983 May; 71(5):1130-40. PubMed ID: 6304144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical mutagenicity and cellular status in vitamins A, E and C.
    Narbonne JF; Cassand P; Daubeze M; Colin C; Leveque F
    Food Addit Contam; 1990; 7 Suppl 1():S48-52. PubMed ID: 2124551
    [No Abstract]   [Full Text] [Related]  

  • 6. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ; Mitchell VD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of dimethylnitrosamine metabolism by some heterocyclic compounds and by substrates and inhibitors of monoamine oxidase in the rat.
    Phillips JC; Bex C; Lake BG; Cottrell RC; Gangolli SD
    Cancer Res; 1982 Sep; 42(9):3761-5. PubMed ID: 7105041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
    Ishii K; Maeda K; Kamataki T; Kato R
    Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenesis in Salmonella after NADH-dependent microsomal activation of dimethylnitrosamine.
    Fong LY; Lee KM; Lin HJ
    Mutat Res; 1982 Aug; 105(1-2):29-36. PubMed ID: 6750374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the metabolism of dimethylnitrosamine in vitro by rat-liver preparations. II. Inhibition by substrates and inhibitors of monoamine oxidase.
    Lake BG; Harris RA; Collins MA; Cottrell RC; Phillips JC; Gangolli SD
    Xenobiotica; 1982 Sep; 12(9):567-79. PubMed ID: 6818776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of lysis in lysogenic bacteria by liver microsomal metabolites of aflatoxin B1.
    Buch JK; Dave PJ
    Indian J Exp Biol; 1980 Oct; 18(10):1162-4. PubMed ID: 6783510
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
    Golan MD; Bücker M; Schmassmann HU; Raphael D; Jung R; Bindel U; Brase HO; Tegtmeyer F; Friedberg T; Lorenz J; Stasiecki P; Oesch F
    Drug Metab Dispos; 1980; 8(3):121-6. PubMed ID: 6104571
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of the mutagenic environmental pollutant, 6-nitrobenzo[a]pyrene: metabolic activation via ring oxidation.
    Fu PP; Chou MW; Yang SK; Beland FA; Kadlubar FF; Casciano DA; Heflich RH; Evans FE
    Biochem Biophys Res Commun; 1982 Apr; 105(3):1037-43. PubMed ID: 7046751
    [No Abstract]   [Full Text] [Related]  

  • 15. [Action of F- on liver metabolism of dimethylnitrosamine and benzo(a)pyrene in the rat].
    Do Phuoc H; Bompart G; Bourbon P; Bouteille L
    Toxicol Eur Res; 1983 Jan; 5(1):31-5. PubMed ID: 6304937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzo[e]pyrene pretreatment of immature, female C57BL/6J mice results in increased bioactivation of aflatoxin B1 in vitro.
    Ma XF; Gibbons JA; Babish JG
    Toxicol Lett; 1991 Dec; 59(1-3):51-8. PubMed ID: 1755035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hydrogen fluoride on benzo[a]pyrene and dimethylnitrosamine metabolism in rats.
    Dophuoc H; Bompart G; Bourbon P
    Naturwissenschaften; 1981 Dec; 68(12):621-2. PubMed ID: 6278331
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between the kinetic parameters of the microsomal benzo(a)pyrene hydroxylase and the mutagenicity of benzo(a)pyrene in vitro [proceedings].
    Poncelet F; de Meester C; Roberfroid M; Mercier M
    Arch Int Physiol Biochim; 1978 May; 86(2):447-8. PubMed ID: 81022
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of testosterone treatment on the ability of female rat liver S9 to activate aflatoxin B1 and 2-aminofluorene in the AMES/Salmonella system.
    Chernesky P; Jayaraj A; Richardson A
    Mutat Res; 1982 Mar; 103(3-6):267-73. PubMed ID: 6806643
    [No Abstract]   [Full Text] [Related]  

  • 20. Interspecies comparisons of in vitro hepatocarcinogenesis.
    Lipsky MM; Cole KE; Hsu IC; Kahng MW; Jones TW; Trump BF
    Prog Clin Biol Res; 1990; 331():395-408. PubMed ID: 2107552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.